December 7, 2016
…School of Pharmacy and Pharmaceutical Sciences at University of California San Diego have now determined the 3D structure of CCR2 simultaneously bound to two inhibitors. Understanding how these molecules fit together may better enable pharmaceutical companies to develop anti-inflammatory drugs that bind and inhibit CCR2 in a similar manner. The…
October 20, 2020
Scientists set out Oct. 27 to explore the biodiversity of deep sea habitats that are rich in minerals like phosphorus and manganese. The public will be able to see what the scientists see in real time when the researchers guide a remotely operated vehicle as it explores the ocean floor.
June 16, 2020
A first-in-class clinical trial suggests a novel treatment measurably slowed progression of non-alcoholic fatty liver disease to its more progressive and deadly form.
June 8, 2015
The Sanford Consortium for Regenerative Medicine in La Jolla, California, and the Takeda Pharmaceutical Company Limited (Takeda) have agreed to establish a $10-million, five-year Innovation Alliance that would advance each organization’s research missions.
October 10, 2011
A newly developed method for microscopically extracting, or “mining,” information from genomes could represent a significant boost in the search for new therapeutic drugs and improve science’s understanding of basic functions such as how cells communicate with one another.
December 16, 2015
The renewed emphasis on strengthening the university’s “innovation ecosystem” gets a big boost this week with the launch of the UC San Diego Entrepreneurs-in-Residence program.
December 5, 2023
Researchers from the University of California San Diego, West Health, and the University of Washington have found evidence that the private insurers that sponsor Medicare Part D are artificially inflating the costs of certain generic drugs by overpaying pharmacies.
May 1, 2017
The next installment of the UC San Diego series, Evening with an Entrepreneur, will feature scientist, inventor, serial entrepreneur, innovator, and long-time UC San Diego supporter, Dr. Tina Nova. Nova will sit down with Biocom’s Joe Panetta for an interview to discuss her unique entrepreneurial background and success in molecular…
November 16, 2015
…Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired — permanently editing a gene, but only temporarily activating CRISPR-Cas9.
October 29, 2012
Three legendary San Diego venture capitalists will discuss past lessons learned and thoughts about the future of local commercial biotech ventures during the first in a series of planned “conversations” Nov. 7 in Calit2’s Atkinson Hall at UC San Diego. The event is being billed as the first of its…
